Risk-based innovations in cancer screening and diagnosis: a discrete choice experiment to explore priorities of the UK public
There are high levels of public support for risk-based innovations within risk-stratified cancer healthcare, especially for referral decision-making and using genetic and non-invasive tests. Optimising risk-based innovations is needed to engage those whose participation is contingent on test methods and performance metrics.
Authors
- Stephen Morris (ORCID: https://orcid.org/0000-0002-5828-3563)
- Reanna J. Clune (ORCID: https://orcid.org/0009-0009-3988-2841)
- Jo Waller (ORCID: https://orcid.org/0000-0003-4025-9132)
- Juliet A. Usher‐Smith (ORCID: https://orcid.org/0000-0002-8501-2531)
- Rebecca A. Dennison (ORCID: https://orcid.org/0000-0002-0847-0723)
- Stuart Wright (ORCID: https://orcid.org/0000-0002-4064-7998)
Institutions
- Queen Mary University of London (GB)
- University of Cambridge (GB)
- Manchester Academic Health Science Centre (GB)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-093803
- Primary Topic
- Global Cancer Incidence and Screening
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- Cancer Research UK